|Articles|July 6, 2016
Hanmi Selects Medidata Cloud Technology
Medidata has signed a multi-year deal with South Koreas Hanmi Pharmaceuticals.
Advertisement
Medidata has signed a multi-year deal with South Korea's Hanmi Pharmaceuticals. The Seoul-based company is adopting Medidatas Clinical Cloud platform into all clinical trials across its drug development programs.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
2
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
3
AI-Driven Clinical Trial Recruitment and Design
4
ACT Brief: Quality Built Throughout Trial Lifecycle, Agentic RTSM Compression, and State Access Programs
5